Sigma Labs Stock Forecast, Price & News

-0.01 (-0.31 %)
(As of 09/21/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume97,046 shs
Average Volume2.18 million shs
Market Capitalization$33.27 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SGLB News and Ratings via Email

Sign-up to receive the latest news and ratings for Sigma Labs and its competitors with MarketBeat's FREE daily newsletter.

Sigma Labs logo

About Sigma Labs

Sigma Labs, Inc. engages in the development and commercialization of computer aided inspection solutions under the PrintRite3D brand. Its software provides the following features: monitoring, analysis, feedback, and control; third-party validated technology; retrofit or integrated installations; thermal signature anomaly detection plus automatic risk-level classification; and statistical process sampling and analytics. The company was founded by Mark J. Cola and Vivek R. Dave on December 23, 1985 and is headquartered in Santa Fe, NM.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.73 out of 5 stars

Business Services Sector

223rd out of 392 stocks

Miscellaneous Manufacturing Industries Industry

9th out of 13 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Sigma Labs (NASDAQ:SGLB) Frequently Asked Questions

Is Sigma Labs a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sigma Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sigma Labs stock.
View analyst ratings for Sigma Labs
or view top-rated stocks.

What stocks does MarketBeat like better than Sigma Labs?

Wall Street analysts have given Sigma Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sigma Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sigma Labs?

Sigma Labs saw a drop in short interest in August. As of August 31st, there was short interest totaling 781,800 shares, a drop of 20.6% from the August 15th total of 984,600 shares. Based on an average daily volume of 551,600 shares, the short-interest ratio is currently 1.4 days. Currently, 7.7% of the company's shares are short sold.
View Sigma Labs' Short Interest

When is Sigma Labs' next earnings date?

Sigma Labs is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for Sigma Labs

How were Sigma Labs' earnings last quarter?

Sigma Labs, Inc. (NASDAQ:SGLB) issued its quarterly earnings results on Thursday, July, 22nd. The company reported ($0.18) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.05. The company earned $0.14 million during the quarter, compared to analyst estimates of $0.59 million. Sigma Labs had a negative net margin of 509.70% and a negative trailing twelve-month return on equity of 50.72%.
View Sigma Labs' earnings history

How has Sigma Labs' stock price been impacted by COVID-19 (Coronavirus)?

Sigma Labs' stock was trading at $4.76 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SGLB shares have decreased by 31.3% and is now trading at $3.27.
View which stocks have been most impacted by COVID-19

What price target have analysts set for SGLB?

1 equities research analysts have issued 1 year price objectives for Sigma Labs' stock. Their forecasts range from $6.00 to $6.00. On average, they expect Sigma Labs' stock price to reach $6.00 in the next year. This suggests a possible upside of 83.5% from the stock's current price.
View analysts' price targets for Sigma Labs
or view top-rated stocks among Wall Street analysts.

Who are Sigma Labs' key executives?

Sigma Labs' management team includes the following people:
  • Mark K. Ruport, President, Chief Executive Officer & Director
  • Frank Donald Orzechowski, Chief Financial Officer, Secretary & Treasurer
  • Darren P. Beckett, Chief Technology Officer
  • Ronald Fisher, Vice President-Business Development
  • Markus Meidenstein, Manager-Business Development

Who are some of Sigma Labs' key competitors?

What other stocks do shareholders of Sigma Labs own?

What is Sigma Labs' stock symbol?

Sigma Labs trades on the NASDAQ under the ticker symbol "SGLB."

Who are Sigma Labs' major shareholders?

Sigma Labs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include AWM Investment Company Inc. (6.65%), Vanguard Group Inc. (1.25%), Essex Investment Management Co. LLC (0.99%), Geode Capital Management LLC (0.79%), Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%).
View institutional ownership trends for Sigma Labs

Which major investors are selling Sigma Labs stock?

SGLB stock was sold by a variety of institutional investors in the last quarter, including Wolverine Trading LLC, and Cutler Group LP.
View insider buying and selling activity for Sigma Labs
or view top insider-selling stocks.

Which major investors are buying Sigma Labs stock?

SGLB stock was purchased by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, AWM Investment Company Inc., Vanguard Group Inc., Geode Capital Management LLC, Simplex Trading LLC, State Street Corp, HAP Trading LLC, and Citadel Advisors LLC.
View insider buying and selling activity for Sigma Labs
or or view top insider-buying stocks.

How do I buy shares of Sigma Labs?

Shares of SGLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sigma Labs' stock price today?

One share of SGLB stock can currently be purchased for approximately $3.27.

How much money does Sigma Labs make?

Sigma Labs has a market capitalization of $34.32 million and generates $810,000.00 in revenue each year. The company earns $-5,200,000.00 in net income (profit) each year or ($1.83) on an earnings per share basis.

How many employees does Sigma Labs have?

Sigma Labs employs 20 workers across the globe.

What is Sigma Labs' official website?

The official website for Sigma Labs is

Where are Sigma Labs' headquarters?

Sigma Labs is headquartered at 3900 PASEO DEL SOL, SANTA FE NM, 87507.

How can I contact Sigma Labs?

Sigma Labs' mailing address is 3900 PASEO DEL SOL, SANTA FE NM, 87507. The company can be reached via phone at (505) 438-2576 or via email at [email protected].

This page was last updated on 9/21/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.